Back
Moderna 10K Form
Sell
28
MRNA
Moderna
Last Price:
$34.62
Seasonality Move:
35.18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MRNA News And Ratings
See the #1 stock for the next 7 days that we like better than MRNA
MRNA Financial Statistics
Sales & Book Value
| Annual Sales: | $3.2B |
|---|---|
| Cash Flow: | $303M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $28.24 |
| Price / Book: | 1.23 |
Profitability
| EPS (TTM): | -9.28000 |
|---|---|
| Net Income (TTM): | $-3.6B |
| Gross Margin: | $1.7B |
| Return on Equity: | -29.09% |
| Return on Assets: | -22.04% |
Moderna Earnings Forecast
Key Moderna Financial Ratios
-
The Gross Profit Margin over the past 7 years for MRNA is 54.24%.
-
The Selling, General & Administrative Expenses for MRNA have been equal to 36.70% of Gross Profit Margin.
-
The Research & Development expenses have been 142.01% of Revenue.
-
The Net Earning history of MRNA is -111.32% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Moderna Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MRNA |
| CUSIP: | 60770K |
| Website: | modernatx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.67 |
| Quick Ratio: | 3.45 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |